{"result": "{\n    \"title\": \"Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Community\",\n    \"summary\": \"The community focuses on the Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) and its associated medical conditions, treatments, and management protocols. Key entities include medications like Tolvaptán and Furosemida, as well as the multidisciplinary algorithm for managing hyponatremia, which is a significant consequence of SIADH. The relationships among these entities highlight the complexity of treatment and the importance of careful management of sodium levels in affected patients.\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the critical nature of SIADH and its potential complications, including severe hyponatremia.\",\n    \"findings\": [\n        {\n            \"summary\": \"SIADH as a significant clinical condition\",\n            \"explanation\": \"The Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) is a major clinical condition that leads to excessive water retention and dilutional hyponatremia, affecting a large number of hospitalized patients. SIADH is responsible for approximately 95% of cases of hyponatremia in these patients, necessitating careful monitoring and management of sodium levels. The condition's prevalence and potential complications underscore its importance in clinical practice. [Data: Entities (4389); Relationships (3096)]\"\n        },\n        {\n            \"summary\": \"Role of Tolvaptán in managing hyponatremia\",\n            \"explanation\": \"Tolvaptán is a key medication used to treat hyponatremia associated with SIADH. It functions as a vasopressin receptor antagonist, promoting renal water excretion and thereby helping to correct sodium levels in the blood. This medication is particularly effective in patients suffering from heart failure and those receiving artificial nutrition, making it a vital component of the treatment protocol for SIADH-related hyponatremia. [Data: Entities (4466); Relationships (3131, 5903)]\"\n        },\n        {\n            \"summary\": \"Furosemida's role in fluid management\",\n            \"explanation\": \"Furosemida, or Furosemide, is a diuretic medication that plays a crucial role in managing fluid retention and high blood pressure in patients with SIADH. It aids in the elimination of free water, which is essential for correcting the fluid imbalance caused by excessive ADH secretion. The use of Furosemida in conjunction with other treatments highlights the complexity of managing SIADH and the need for a multifaceted approach. [Data: Entities (4472); Relationships (3134, 929)]\"\n        },\n        {\n            \"summary\": \"Multidisciplinary algorithm for SIADH management\",\n            \"explanation\": \"The 'ALGORITMO MULTIDISCIPLINAR' is a comprehensive treatment protocol designed for managing patients with hyponatremia, particularly those with SIADH. This algorithm integrates various medical disciplines to provide a holistic approach to patient care, ensuring that all aspects of the condition are addressed. The algorithm's significance lies in its structured approach to treatment, which is essential for effective management of this complex condition. [Data: Entities (4487); Relationships (3135)]\"\n        },\n        {\n            \"summary\": \"Impact of underlying conditions on SIADH\",\n            \"explanation\": \"Several underlying conditions, such as tumors, cerebrovascular accidents, and pulmonary diseases, can lead to the development of SIADH. These conditions can cause ectopic production of ADH or disrupt normal fluid balance, resulting in hyponatremia. Understanding these relationships is crucial for clinicians in diagnosing and managing SIADH effectively, as addressing the underlying causes can significantly impact treatment outcomes. [Data: Entities (2950, 4478, 4432); Relationships (4969, 5908, 5898)]\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\r\n4389,SIADH,\"The Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) is a medical condition characterized by the excessive release of antidiuretic hormone (ADH), which results in water retention and dilutional hyponatremia. This condition is responsible for approximately 95% of cases of hyponatremia in hospitalized patients. SIADH leads to low sodium levels in the blood, necessitating careful management of sodium levels, often through medication. The excessive production of ADH causes the body to retain water, which ultimately contributes to the development of hyponatremia. Overall, SIADH is a significant clinical condition that requires attention due to its impact on electrolyte balance and fluid management in affected individuals.\",36\r\n4466,TOLVAPTÁN,\"Tolvaptán is a medication that functions as a vasopressin receptor antagonist, primarily used to treat hyponatremia, which is a condition characterized by low sodium levels in the blood. It is particularly effective in patients suffering from heart failure, those receiving artificial nutrition, and individuals with conditions such as the Syndrome of Inappropriate Antidiuretic Hormone secretion (SIADH). By promoting renal water excretion, Tolvaptán helps manage sodium levels in these patients. The medication is administered in specific dosages to ensure effective treatment and is approved for use in Europe for addressing hyponatremia associated with SIADH.\",8\r\n4472,FURSEMIDA,\"FURSEMIDA, also known as Furosemida, is a diuretic medication utilized primarily to treat fluid retention and high blood pressure. It is effective in promoting the elimination of free water, making it particularly useful for patients with Syndrome of Inappropriate Antidiuretic Hormone secretion (SIADH). Furosemida can be administered either intravenously or orally, depending on the patient's needs.\",6\r\n4487,ALGORITMO MULTIDISCIPLINAR,\"The \"\"ALGORITMO MULTIDISCIPLINAR\"\" is a comprehensive multidisciplinary algorithm designed for the management of patients with hyponatremia, especially those who are receiving artificial nutrition. This algorithm serves as a detailed treatment protocol that outlines the necessary steps for effectively managing patients with the Syndrome of Inappropriate Antidiuretic Hormone secretion (SIADH). By integrating various medical disciplines, the algorithm aims to provide a holistic approach to patient care in these specific clinical scenarios.\",2\r\n4467,CONIVAPTÁN,\"Conivaptán is a medication administered intravenously to treat hyponatremia, particularly in cases associated with the Syndrome of Inappropriate Antidiuretic Hormone secretion (SIADH). It functions as a vasopressin receptor antagonist, specifically blocking the V2 receptor, which promotes the excretion of water. By doing so, Conivaptán aids in correcting sodium levels in the blood, making it an effective treatment option for managing this electrolyte imbalance.\",2\r\n4400,BLOQUE: SOPORTE NUTRICIONAL AVANZADO,This section discusses advanced nutritional support aimed at conserving body water in situations that pose a potential threat to the organism.,2\r\n2950,TUMORES,\"Tumors can be a cause of Syndrome of Inappropriate Antidiuretic Hormone secretion (SIADH), particularly pulmonary and non-thoracic tumors.\",2\r\n4478,ACCIDENTE CEREBROVASCULAR,\"Cerebrovascular accidents (strokes) can lead to SIADH, resulting in altered sodium levels in the blood.\",1\r\n4430,ACV,\"Accidente cerebrovascular (ACV) refers to a stroke, which can be a cause of SIADH as mentioned in the text.\",1\r\n4402,CEREBRAL EDEMA,\"Cerebral edema is a condition that can occur due to the movement of water into the intracellular space, often as a result of hyponatremia.\",1\r\n4428,ELLISON DH,\"Ellison DH is a researcher who contributed to the diagnostic criteria for SIADH, as referenced in the New England Journal of Medicine.\",1\r\n4432,ENFERMEDADES PULMONARES,\"Pulmonary diseases can lead to SIADH, including infections and mechanical ventilation issues.\",1\r\n4494,FLUDROCORTISONA,Fludrocortisona is a medication used to treat conditions related to aldosterone deficiency.,1\r\n4476,HEMORRAGIA SUBARACNOIDEA,\"Subarachnoid hemorrhage is a type of bleeding that can result in SIADH, impacting fluid balance and sodium levels.\",1\r\n4481,HIPERNATREMIA,Hypernatremia is a condition that can occur if patients do not adequately manage their fluid intake while being treated for SIADH.,1\r\n4431,HORMONA ANTIDIURÉTICA,Antidiuretic hormone (ADH) is a hormone that helps regulate water balance in the body and is involved in the pathophysiology of SIADH.,1\r\n4480,INDUCIDO POR FÁRMACOS,\"Drug-induced SIADH occurs when certain medications cause inappropriate secretion of ADH, leading to fluid retention and low sodium levels.\",1\r\n4479,LESIONES CEREBRALES INFLAMATORIAS,\"Inflammatory brain injuries can lead to SIADH, impacting the regulation of water and sodium in the body.\",1\r\n4477,MASAS CEREBRALES,\"Brain masses can cause SIADH by affecting the secretion of ADH, leading to water retention and hyponatremia.\",1\r\n4493,NEFROLOGÍA,Nefrología is a medical journal that published guidelines for managing SIADH in 2014.,1\r\n4418,NEOPLASIA,\"Neoplasia refers to the abnormal growth of tissue, which can sometimes lead to ectopic production of hormones like ADH, contributing to conditions such as SIADH and hiponatremia.\",1\r\n4429,VERBALIS ET AL.,\"Verbalis et al. are researchers who provided insights into the main causes of SIADH, as referenced in The American Journal of Medicine.\",1\r\n4482,TUMOR PRODUCTOR DE ADH,,1\r\n1725,VIH,\"HIV (Human Immunodeficiency Virus) is a virus that attacks the immune system, resulting in increased susceptibility to infections, including respiratory diseases. It can lead to acquired immunodeficiency syndrome (AIDS), a condition characterized by a severely weakened immune system. Additionally, HIV is noted as a potential cause of syndrome of inappropriate antidiuretic hormone secretion (SIADH), further complicating the health issues associated with the virus.\",1\r\n4459,DESMOPRESINA,\"Desmopresina is a medication utilized in the management of certain types of hyponatremia, a condition characterized by low sodium levels in the blood. It works by inhibiting the secretion of antidiuretic hormone (ADH), which helps to regulate sodium levels. Desmopresina is often used in conjunction with tolvaptán, particularly in cases where sodium levels rise too quickly. Overall, it plays a crucial role in controlling sodium levels and addressing the complications associated with hyponatremia.\",2\r\n4486,PROTOCOLO,Protocolo refers to the established guidelines for administering tolvaptán and managing sodium levels in patients with SIADH.,2\r\n4484,FARMACO,\"Farmaco refers to medications used in the treatment of various conditions, including tolvaptán and desmopresina for managing sodium levels.\",1\r\n4485,TRANSAMINASAS,\"Transaminasas are enzymes that can indicate liver function, and their levels are monitored during treatment to avoid complications.\",1\r\n4474,CALCEMIA,\"Calcemia refers to the concentration of calcium in the blood, which can be affected by various treatments and conditions.\",1\r\n4473,NEFONA,Nefona refers to the functional unit of the kidney responsible for filtering blood and producing urine.,1\r\n4475,MAGNESEMIA,\"Magnesemia refers to the concentration of magnesium in the blood, important for various physiological functions.\",1\r\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\r\n665,NUTRICIÓN PARENTERAL,SIADH,Nutrición parenteral is also mentioned as a method to manage fluid and sodium intake in patients with SIADH,286\r\n246,NUTRICIÓN ENTERAL,SIADH,Nutrición enteral is mentioned as a method to manage fluid and sodium intake in patients with SIADH,252\r\n3096,HIPONATREMIA,SIADH,\"Hyponatremia is a common and significant consequence of Syndrome of Inappropriate Antidiuretic Hormone secretion (SIADH). In SIADH, there is an excessive secretion of antidiuretic hormone (ADH), which results in increased water retention in the body. This excessive water retention dilutes sodium levels in the bloodstream, leading to hyponatremia. Therefore, SIADH is recognized as a direct cause of hyponatremia, necessitating careful management to address the low sodium levels associated with this condition.\",102\r\n926,NUTRICIÓN ARTIFICIAL,SIADH,\"NUTRICIÓN ARTIFICIAL refers to the provision of nutrients through means other than oral intake, which can significantly impact fluid balance in patients. It has been noted that artificial nutrition may be associated with the syndrome of inappropriate antidiuretic hormone secretion (SIADH). This condition can lead to hyponatremia, a state of low sodium levels in the blood. The influence of artificial nutrition on the development of hyponatremia is particularly relevant in patients diagnosed with SIADH, as it can affect the management of sodium levels in these individuals. Therefore, careful consideration of artificial nutrition is essential in the context of SIADH to ensure proper fluid and electrolyte balance.\",90\r\n3131,HIPONATREMIA,TOLVAPTÁN,\"Tolvaptán is a medication specifically used to treat the condition of hiponatremia, which is characterized by low sodium levels in the blood. It works by promoting the excretion of free water, thereby helping to correct sodium levels and increase their concentration in the bloodstream. Through this mechanism, Tolvaptán effectively addresses the underlying issue of hiponatremia, making it a valuable treatment option for patients suffering from this condition.\",74\r\n3134,HIPONATREMIA,FURSEMIDA,Furosemide is used as part of the treatment protocol for managing hyponatremia,72\r\n3135,HIPONATREMIA,ALGORITMO MULTIDISCIPLINAR,The multidisciplinary algorithm provides guidelines for the treatment of hyponatremia,68\r\n3132,HIPONATREMIA,CONIVAPTÁN,\"Conivaptán is also used to treat hiponatremia, functioning similarly to Tolvaptán\",68\r\n929,NUTRICIÓN ARTIFICIAL,FURSEMIDA,\"Furosemida may interact with artificial nutrition, affecting fluid balance\",60\r\n5883,ADH,SIADH,\"ADH, or antidiuretic hormone, is the hormone that is inappropriately secreted in the condition known as SIADH, which stands for Syndrome of Inappropriate Antidiuretic Hormone secretion. This inappropriate secretion of ADH results in excessive water retention in the body, leading to a dilution of sodium levels in the blood, a condition known as hyponatremia. Thus, SIADH is characterized by the inappropriate secretion of ADH, which causes significant physiological effects, primarily water retention and the subsequent development of hyponatremia.\",48\r\n5900,SIADH,HIPONATREMIA EUVOLÉMICA,El SIADH es una de las causas más frecuentes de hiponatremia euvolémica en pacientes con nutrición artificial.,47\r\n5903,SIADH,TOLVAPTÁN,\"Tolvaptán is a medication indicated for the treatment of hyponatremia associated with the syndrome of inappropriate antidiuretic hormone secretion (SIADH). It serves as a treatment option for patients suffering from hyponatremia related to SIADH by promoting the excretion of water, thereby helping to manage sodium levels in affected individuals. Through its mechanism of action, Tolvaptán effectively addresses the condition of SIADH by correcting the imbalance in sodium levels, making it a valuable therapeutic choice for this specific type of hyponatremia.\",44\r\n5901,SIADH,FURSEMIDA,\"Furosemida, a loop diuretic, is utilized in the management of fluid retention in patients diagnosed with SIADH (Syndrome of Inappropriate Antidiuretic Hormone secretion). It aids in treating these patients by promoting the elimination of free water, thereby helping to alleviate the symptoms associated with fluid overload.\",42\r\n5332,FUROSEMIDA,SIADH,Furosemida is mentioned as a treatment option for conditions related to SIADH,41\r\n5912,SIADH,HIDROCORTISONA,Hidrocortisona is administered in cases of primary adrenal insufficiency related to SIADH,39\r\n3509,INSUFICIENCIA RESPIRATORIA,SIADH,Respiratory failure can be associated with SIADH,39\r\n5891,SIADH,BLOQUE: SOPORTE NUTRICIONAL AVANZADO,The section on advanced nutritional support discusses the implications of SIADH on body water conservation,38\r\n5904,SIADH,CONIVAPTÁN,Conivaptán is used to treat hyponatremia secondary to SIADH,38\r\n5899,SIADH,SÍNDROME DE INMUNODEFICIENCIA ADQUIRIDA,\"AIDS is mentioned as a potential cause of SIADH, establishing a relationship\",38\r\n5902,SIADH,UREA,\"Urea is mentioned as a treatment option for SIADH, although it has significant drawbacks\",38\r\n25,NEUMONÍA,SIADH,Pneumonia can induce SIADH,38\r\n4969,TUMORES,SIADH,\"Certain tumors are known to cause SIADH, establishing a direct relationship\",38\r\n5631,TRAUMATISMO CRANEOENCEFÁLICO,SIADH,Head trauma can result in SIADH,38\r\n5703,HYPONATREMIA,SIADH,Hyponatremia is often a result of SIADH,38\r\n5908,SIADH,ACCIDENTE CEREBROVASCULAR,Cerebrovascular accidents can lead to the development of SIADH,37\r\n5896,SIADH,ACV,\"ACV is listed as a potential cause of SIADH, indicating a relationship between the two\",37\r\n5892,SIADH,CEREBRAL EDEMA,Cerebral edema can be a clinical manifestation resulting from the effects of SIADH and subsequent hyponatremia,37\r\n5894,SIADH,ELLISON DH,\"Ellison DH contributed to the diagnostic criteria for SIADH, providing essential insights into its diagnosis\",37\r\n5898,SIADH,ENFERMEDADES PULMONARES,\"Pulmonary diseases can lead to the development of SIADH, indicating a clear relationship\",37\r\n5913,SIADH,FLUDROCORTISONA,\"Fludrocortisona is used in cases of isolated aldosterone deficiency, which can be related to SIADH\",37\r\n5906,SIADH,HEMORRAGIA SUBARACNOIDEA,Subarachnoid hemorrhage can trigger SIADH,37\r\n5911,SIADH,HIPERNATREMIA,Hypernatremia can occur if fluid intake is not managed properly in SIADH patients,37\r\n5897,SIADH,HORMONA ANTIDIURÉTICA,\"ADH is central to the pathophysiology of SIADH, as its inappropriate secretion leads to the condition\",37\r\n5910,SIADH,INDUCIDO POR FÁRMACOS,Drug-induced conditions can lead to SIADH,37\r\n5909,SIADH,LESIONES CEREBRALES INFLAMATORIAS,Inflammatory brain injuries can lead to SIADH,37\r\n5907,SIADH,MASAS CEREBRALES,Brain masses can cause SIADH by affecting ADH secretion,37\r\n5914,SIADH,NEFROLOGÍA,Nefrología published guidelines for the management of SIADH,37\r\n5893,SIADH,NEOPLASIA,\"Neoplasia can lead to ectopic production of ADH, which is a cause of SIADH and subsequently hiponatremia.\",37\r\n5895,SIADH,VERBALIS ET AL.,\"Verbalis et al. provided information on the main causes of SIADH, contributing to the understanding of the condition\",37\r\n5905,SIADH,TUMOR PRODUCTOR DE ADH,Tumors producing ADH can lead to the development of SIADH,37\r\n3753,VIH,SIADH,HIV can lead to SIADH as a complication,37\r\n5928,HIPONATREMIA EUVOLÉMICA,DESMOPRESINA,La desmopresina se utiliza para controlar la hiponatremia euvolémica al inhibir la secreción de ADH.,13\r\n2878,EUROPA,TOLVAPTÁN,Tolvaptán is available in Europe for treating SIADH-related hyponatremia,12\r\n5878,NATREMIA,TOLVAPTÁN,Tolvaptán treatment involves monitoring natremia to ensure sodium levels are within the desired range,12\r\n5938,DESMOPRESINA,TOLVAPTÁN,Desmopresina is used alongside tolvaptán to manage sodium levels when they rise too quickly,10\r\n5941,TOLVAPTÁN,PROTOCOLO,The protocolo outlines the administration and dosage of tolvaptán for effective treatment,10\r\n5939,TOLVAPTÁN,FARMACO,Tolvaptán is a type of farmaco used in the treatment of conditions like SIADH and hiponatremia,9\r\n5940,TOLVAPTÁN,TRANSAMINASAS,Monitoring transaminasas is important during tolvaptán treatment to prevent liver-related complications,9\r\n4965,CELULAS HEMATOPOYETICAS,TUMORES,El estado nutricional de los pacientes con tumores es un factor importante a considerar antes de un trasplante de células hematopoyéticas.,8\r\n5943,FURSEMIDA,CALCEMIA,Furosemida can induce changes in calcemia due to its effects on renal function,7\r\n5942,FURSEMIDA,NEFONA,Furosemida acts on the nefona to promote the elimination of free water,7\r\n5944,FURSEMIDA,MAGNESEMIA,Furosemida may also affect magnesemia through its diuretic action,7\r\n5918,BLOQUE: SOPORTE NUTRICIONAL AVANZADO,BERL T,Berl T's work is referenced in the context of renal water elimination and its relevance to nutritional support,5\r\n5945,PROTOCOLO,ALGORITMO MULTIDISCIPLINAR,The algoritmo multidisciplinar serves as a detailed protocol for managing SIADH and related treatments,4\r\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": 1}, "history": null}